Scarica l'app Stockscreener
4.69
11.93%
0.50
Dopo l'orario di chiusura:
4.68
-0.01
-0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CDLX Giù?
Forum
Previsione
Cardlytics Inc Borsa (CDLX) Ultime notizie
After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar - Simply Wall St
Cardlytics Appoints Srishti Gupta to Board of Directors - TipRanks
Cardlytics Rings the Closing Bell - Nasdaq
Cardlytics, Inc. (NASDAQ:CDLX) Short Interest Down 8.2% in October - MarketBeat
Cardlytics (CDLX) to Release Earnings on Wednesday - MarketBeat
SG Americas Securities LLC Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - Defense World
Cardlytics CEO Amit Gupta sells shares worth $86,923 By Investing.com - Investing.com Australia
Brokerages Set Cardlytics, Inc. (NASDAQ:CDLX) Target Price at $6.92 - Defense World
Cardlytics CEO Amit Gupta sells shares worth $86,923 - Investing.com
Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 22,607 Shares of Stock - MarketBeat
Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release - GlobeNewswire
Cardlytics Inc (CDLX-Q) QuotePress Release - The Globe and Mail
Cardlytics, Inc. (NASDAQ:CDLX) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Gaining Ground: Cardlytics Inc (CDLX) Closes Higher at 3.78, Up 0.13 - The Dwinnex
A look into Cardlytics Inc (CDLX)’s deeper side - SETE News
Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt? - Simply Wall St
Cardlytics Inc (CDLX) rating initates by Evercore ISI - Knox Daily
Cardlytics (NASDAQ:CDLX) Now Covered by Evercore ISI - Defense World
Evercore ISI initiates coverage on Cardlytics shares with In Line rating By Investing.com - Investing.com South Africa
The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts - Benzinga
Cardlytics (NASDAQ:CDLX) Coverage Initiated at Evercore ISI - MarketBeat
Evercore ISI initiates coverage on Cardlytics shares with In Line rating - Investing.com
Cardlytics, Inc. (NASDAQ:CDLX) Stock Holdings Decreased by Dimensional Fund Advisors LP - MarketBeat
Lake Street Initiates Coverage of Cardlytics (CDLX) with Buy Recommendation - MSN
Cardlytics CFO sells shares worth over $23,000 By Investing.com - Investing.com Australia
Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells $18,282.88 in Stock - MarketBeat
Cardlytics CFO sells shares worth over $23,000 - Investing.com India
Cardlytics executive sells over $18k in company stock By Investing.com - Investing.com South Africa
Cardlytics CEO sells shares worth over $23k - Investing.com
Cardlytics CEO sells shares worth over $23k By Investing.com - Investing.com UK
Renaissance Technologies LLC Has $2.88 Million Stock Holdings in Cardlytics, Inc. (NASDAQ:CDLX) - MarketBeat
Renaissance Technologies LLC Buys 307,800 Shares of Cardlytics, Inc. (NASDAQ:CDLX) - MarketBeat
Bragar Eagel & Squire, P.C. Is Investigating Cardlytics, Medpace, Customers Bancorp, and ... - Post Register
Bragar Eagel & Squire, P.C. Is Investigating Cardlytics, - GlobeNewswire
Is Cardlytics, Inc. (CDLX) the Worst Advertising Stock to Buy According to Short Sellers? - Insider Monkey
CDLX Shares Experience Decline in Value - Knox Daily
Is Cardlytics, Inc. (CDLX) the Worst Marketing Stock to Buy? - Insider Monkey
Cardlytics, Inc. (NASDAQ:CDLX) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cardlytics, Inc.CDLX - PR Newswire
Views of Wall Street’s Leading Experts on Cardlytics Inc - SETE News
Cardlytics, Inc. (CDLX): A Bull Case Theory - Insider Monkey
10 Worst Marketing Stocks to Buy - Insider Monkey
Understanding the Risks of Investing in Cardlytics Inc (CDLX) - Knox Daily
Stifel’s latest rating for CLDX stock - Knox Daily
Closing Figures Unveiled: Cardlytics Inc (CDLX) Drop -5.41, Closes at 3.67 - The Dwinnex
Cosciens Biopharma Shares Fall on ALS Treatment Research End, Cost Cutting - MarketWatch
DRW Securities LLC Acquires New Holdings in Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) - Defense World
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):